Olynth nasal spray

Olynth is a widely recognized pharmaceutical brand specializing in nasal care products, particularly decongestant sprays used to treat rhinitis and sinusitis. The brand was originally developed and marketed by the German company Gödecke, which later became part of Pfizer.

In 2006, as part of a major acquisition, the brand was integrated into the Johnson & Johnson portfolio. Most recently, following the corporate spinoff of Johnson & Johnson's consumer health division, Olynth is now owned and managed by Kenvue. While the brand has deep roots in Germany, its manufacturing facilities are distributed across Europe, with major production sites in France catering to the European market.